David Murray

David Murray has a strong background in scientific research, with experiences in companies like Shoreline Biosciences, Inc., Northwestern University, and Loyola University Chicago. Their expertise ranges from NK gene editing to molecular cloning and population genetics. David has also worked on cancer vaccine development at Pfizer. Their work involves detailed studies on gene transcription regulation, therapeutics targets, and designing studies using novel cancer therapeutics.